Molecule Details
| InChIKey | YTIOGZLHYJDYTK-VFFRCKCKSA-N |
|---|---|
| Compound Name | 2-[2-(Morpholine-4-sulfonylamino)-3-phenyl-propionylamino]-pent-4-enoic acid (1-cyclohexylmethyl-2,3-dihydroxy-5-methyl-hexyl)-amide |
| Canonical SMILES | C=CC[C@H](NC(=O)[C@H](Cc1ccccc1)NS(=O)(=O)N1CCOCC1)C(=O)N[C@@H](CC1CCCCC1)[C@@H](O)[C@@H](O)CC(C)C |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 5 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 8.41 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile
Target Activities (5)
| Target | Gene | Organism | Category | Pfam | pChEMBL | Type | Source |
|---|---|---|---|---|---|---|---|
| P00797 | REN | Homo sapiens | Human | PF07966 PF00026 | 9.7 | IC50 | ChEMBL;BindingDB |
| P07339 | CTSD | Homo sapiens | Human | PF07966 PF00026 | 8.6 | Ki | ChEMBL;BindingDB |
| P20142 | PGC | Homo sapiens | Human | PF07966 PF00026 | 8.1 | Ki | ChEMBL;BindingDB |
| P0DJD9 | PGA5 | Homo sapiens | Human | PF07966 PF00026 | 7.9 | Ki | ChEMBL;BindingDB |
| P14091 | CTSE | Homo sapiens | Human | PF07966 PF00026 | 7.8 | Ki | ChEMBL;BindingDB |